BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26221594)

  • 21. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases].
    Li Z; Liu WP; Tang Y; Jiang LL; Zhang WY; Bi CF; Li GD
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):217-22. PubMed ID: 17877195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
    Gu Y; Wu B; Zhang Y; Guo Y; Peng W
    Eur Rev Med Pharmacol Sci; 2014; 18(3):404-12. PubMed ID: 24563442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1.
    Dong G; Li Y; Lee L; Liu X; Shi Y; Liu X; Bouska A; Gong Q; Kong L; Wang J; Lou CH; McKeithan TW; Iqbal J; Chan WC
    Haematologica; 2021 Sep; 106(9):2427-2438. PubMed ID: 32732362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion mapping of the long arm of chromosome 6 in peripheral T and NK cell lymphomas.
    Yoon J; Ko YH
    Leuk Lymphoma; 2003 Dec; 44(12):2077-82. PubMed ID: 14959850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings.
    Yang CF; Hsu CY; Ho DM
    Histopathology; 2018 May; 72(6):955-964. PubMed ID: 29314186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
    Zhang S; Li T; Zhang B; Nong L; Aozasa K
    Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
    Iqbal J; Kucuk C; Deleeuw RJ; Srivastava G; Tam W; Geng H; Klinkebiel D; Christman JK; Patel K; Cao K; Shen L; Dybkaer K; Tsui IF; Ali H; Shimizu N; Au WY; Lam WL; Chan WC
    Leukemia; 2009 Jun; 23(6):1139-51. PubMed ID: 19194464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma: A retrospective cohort study in China.
    Nong L; Zheng Y; Li X; Li D; Liang L; Wang W; Li T
    Pathol Res Pract; 2022 May; 233():153860. PubMed ID: 35429891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
    Kim SH; Kim SH; Yang WI; Kim SJ; Yoon SO
    Oncotarget; 2017 May; 8(19):31305-31317. PubMed ID: 28412742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
    Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
    Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
    Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
    Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
    Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
    Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
    Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
    J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
    Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
    J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of clinicopathological features and prognostic factors of 62 nasal NK/T-cell lymphomas].
    Xu G; Wang H; Xie K; He G; Du Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Oct; 21(20):932-4. PubMed ID: 18254324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.